Advanced Rheumatology Course: All Activities
Program Information
The Advanced Rheumatology Course (ARC) is a comprehensive, 19-module educational series geared toward members of the rheumatology interprofessional team and other professionals needing a deeper dive into rheumatology. Use the course to learn how to assess and manage patients with rheumatic disease, develop strategies to better integrate NP/PAs into rheumatology practice, and improve access to care for patients. The course has a strong focus on advanced information that will help experienced practice providers function well in rheumatology and foster interprofessional collaboration.
Target Audience
The course was created for nurse practitioners and physician assistants; however, rheumatology fellows-in training, internal medicine residents, medical students, primary care providers and other providers new to rheumatology may also benefit.
Learning Objectives
Upon completion of this course, participants should be able to do the following:
- Assess and manage patients with rheumatic diseases as part of an interprofessional collaborative care team.
- Develop strategies to integrate the nurse practitioner and physician assistant into a collaborative rheumatology practice.
- Assist in decreasing wait times for appointments and improve access to care for patients with rheumatic disease by improving the competence and performance of nurse practitioners and physician assistants in a collaborative rheumatology practice.
Advanced Rheumatology Activities
- Activity 1: Musculoskeletal Structure And Function And Inflammation And Immunity
- Activity 2: Framework for Clinical Decision Making in Rheumatology
- Activity 3: Laboratory Evaluation of Rheumatic Disease
- Activity 4: Imaging of Arthritis
- Activity 5: Coding And Practice Issues
- Activity 6: Therapeutic Interventions And Resources
- Activity 7: Osteoarthritis
- Activity 8: RA and Seronegative Inflammatory Arthropathies
- Activity 9: Systemic Lupus Erythematosus
- Activity 10: Systemic Inflammatory Conditions: Inflammatory Myopathy
- Activity 11: Vasculitis, Arteritis and PMR
- Activity 12: Crystal-Induced Arthropathies
- Activity 13: Pain Syndromes
- Activity 14: Spondyloarthritis
- Activity 15: Infection-Related Arthritis
- Activity 16: Osteoporosis And Other Metabolic Bone Disorders
- Activity 17: Comprehensive Overview of Juvenile Idiopathic Arthritis (JIA)
- Activity 18:Comprehensive Overview of Pediatric Connective Tissue Diseases (CTD)
- Activity 19: Pediatric Noninflammatory Musculoskeletal Pain
CME Information
Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.
Designation Statement
The ACR designates this enduring online activity for a maximum of 25.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Health Professionals
Participants may claim hours to receive a Certificate of Participation for an activity designated for AMA PRA Category 1 Credits™.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board(s).
Faculty & Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence based, fair balance, and absence of commercial bias.
Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:
- Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Research grants
- Employment (full or part-time)
- Ownership or partnership
- Consulting fees or other remuneration (payment)
- Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
- Receipt of royalties
- Speakers’ bureau
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
ARC01: Musculoskeletal Structure And Function And Inflammation And Immunity
Authors:
Kenneth S. O’Rourke, MD - No relevant financial relationships to disclose
Rachel M. Wolfe, MD - No relevant financial relationships to disclose
Editors and Reviewers:
Daniel Schaffer, MD – No relevant financial relationships to disclose
Anneke Smith – No relevant financial relationships to disclose
Ben Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose
ARC02: Framework for Clinical Decision Making in Rheumatology
Authors:
Megan Lockwood, MD - No relevant financial relationships to disclose
Editors and Reviewers:
Jennifer Grossman, MD - No relevant financial relationships to disclose
Anneke Smith – No relevant financial relationships to disclose
Sonam Kiwalkar, MD – No relevant financial relationships to disclose
ARC03: Laboratory Evaluation of Rheumatic Disease
Authors:
Beth Jonas, MD – No relevant financial relationships to disclose
Editors and Reviewers:
Laurie Hughell, MPH, PA-C - No relevant financial relationships to disclose
Anneke Smith – No relevant financial relationships to disclose
Ben Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose
ARC04: Imaging of Arthritis
Authors:
Beth Jonas, MD – No relevant financial relationships to disclose
Editors and Reviewers:
Laurie Hughell, MPH, PA-C - No relevant financial relationships to disclose
Anneke Smith – No relevant financial relationships to disclose
Ben Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose
ARC05: Coding And Practice Issues
Author:
J. Eugene Huffstutter, MD - No relevant financial relationships to disclose
Editors and Reviewers:
Fredrica Smith, MD - No relevant financial relationships to disclose
Julie Lahti - No relevant financial relationships to disclose
Ben Smith, DMSc, PA-C, DFAAPA - No relevant financial relationships to disclose
ARC06: Therapeutic Interventions And Resources
Authors:
Donna Everix, MPH, PT - No relevant financial relationships to disclose
Jennifer Trizuto, DPT - No relevant financial relationships to disclose
Editors and Reviewers:
Marie Westby, PT, PhD - Janssen Canada5; Ended 2020; Pfizer5; Ended 2020
Julie Lahti - No relevant financial relationships to disclose
Ben Smith, DMSc, PA-C, DFAAPA - No relevant financial relationships to disclose
ARC07: Osteoarthritis
Authors:
Abhijeet Danve, MD – AbbVie/Abbott1; Novartis1
Yuliya Afinogenova, MD - No relevant financial relationships to disclose
Swetha Alexander, MD - No relevant financial relationships to disclose
Editors and Reviewers:
Janeth Yinh, MD – No relevant financial relationships to disclose
Anneke Smith – No relevant financial relationships to disclose
Sonam Kiwalkar, MD – No relevant financial relationships to disclose
ARC08: RA and Seronegative Inflammatory Arthropathies
Authors:
Gregory C. Gardner, MD, MACP – No relevant financial relationships to disclose
Editors and Reviewers:
Sheila Arvikar, MD – No relevant financial relationships to disclose
Julie Lahti - No relevant financial relationships to disclose
Sonam Kiwalkar, MD – No relevant financial relationships to disclose
ARC09: Systemic Lupus Erythematosus
Authors:
Mary Chester Wasko, MD, AbbVie/Abbott2; AstraZeneca2; EMD Serono2; GlaxoSmithKlein2; HGS2; Roche2
Joanna Marco, MD – No relevant financial relationships to disclose
Editors and Reviewers:
Paul Monach, MD, PhD – Celgene1; Chemocentryx6; Kiniksa16
Anneke Smith – No relevant financial relationships to disclose
Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2
ARC10: Systemic Inflammatory Conditions
Authors:
Jason Kolfenbach, MD: ChemoCentryx5
Tara Skorupa, MD: No relevant financial relationships to disclose
Editors and Reviewers:
Zsuzsanna McMahon – No relevant financial relationships to disclose
Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2
Julie Lahti – No relevant financial relationships to disclose
ARC11: Vasculitis, Arteritis and PMR
Authors:
Anisha Dua, MD - AbbVie/Abbott5, 8; ChemoCentryx5; Novartis5
Josh Waytz, MD – No relevant financial relationships to disclose
Editors and Reviewers:
Paul Monach, MD, PhD – Celgene1; Chemocentryx6; Kiniksa
Anneke Smith – No relevant financial relationships to disclose
Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2
ARC12: Crystal-Induced Arthropathies
Authors:
Puja Khanna, MD – DYVE2; Horizon1,2,5; Select1,2
Editors and Reviewers:
Chio Yokose, MD – No relevant financial relationships to disclose
Anneke Smith – No relevant financial relationships to disclose
Sonam Kiwalkar, MD – No relevant financial relationships to disclose
ARC13: Pain Syndromes
Authors:
Andrew Heisler, MD – No relevant financial relationships to disclose
Editors and Reviewers:
Sonam Kiwalkar, MD – No relevant financial relationships to disclose
Christine Stamatos, DNP – No relevant financial relationships to disclose
Julie Lahti – No relevant financial relationships to disclose
ARC14: Spondyloarthritis
Authors:
Atul Deodhar, MD - AbbVie/Abbott528; Amgen528; BMS528; Boheringer Ingelheim528; Celgene528; Gilead528; Glapagos528; Janssen528; Lilly528; Novartis528; Pfizer528; UCB528
Anand Kumthekar, MD – No relevant financial relationships to disclose
Planning Committee/Content Reviewers Disclosures:
Abhijeet Danve, MD – AbbVie/Abbott1; Novartis1
Anneke Smith – No relevant financial relationships to disclose
Sonam Kiwalkar, MD – No relevant financial relationships to disclose
ARC15: Infection-Related Arthritis
Authors:
Robert A. Kalish, MD – No relevant financial relationships to disclose
Janet Hong, MD – No relevant financial relationships to disclose
Frank Scangarello, MD, PhD – No relevant financial relationships to disclose
Editors and Reviewers:
Michael Battistone, MD – American Board of Internal Medicine Rheumatology Exam Committee6: Advisor or Review Panel member
Anneke Smith – No relevant financial relationships to disclose
Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2
ARC16: Osteoporosis And Other Metabolic Bone Disorders
Authors:
Sarah Keller, MD – No relevant financial relationships to disclose
Editors and Reviewers:
Alfred Denio, MD – Abbvie8; Bristol-Myers Squibb5
Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2
Julie Lahti – No relevant financial relationships to disclose
ARC17: Comprehensive Overview of Juvenile Idiopathic Arthritis (JIA)
Authors:
Betsy Roth-Wojcicki, RN, MS, CPNP-PC - No relevant financial relationships to disclose
Editors and Reviewers:
Heather Benham, APRN, CPNP, DNP, RhMSUS – No relevant financial relationships to disclose
Anneke Smith - No relevant financial relationships to disclose
Ben Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose
ARC18: Comprehensive Overview of Pediatric Connective Tissue Diseases (CTD)
Authors:
Heather Benham, DNP, APRN, CPNP-PC, RhMSUS – No relevant financial relationships to disclose
Editors and Reviewers:
Natasha Ruth, MD, MS – No relevant financial relationships to disclose
Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2
Julie Lahti – No relevant financial relationships to disclose
ARC19: Pediatric Noninflammatory Musculoskeletal Pain
Authors:
Bethany A. Marston, MD – No relevant financial relationships to disclose
Editors and Reviewers:
Susan Shenoi, MS, MBBS, RhMSUS – Pfizer5
Julie Lahti - No relevant financial relationships to disclose
Sonam Kiwalkar, MD – No relevant financial relationships to disclose
*All of the relevant financial relationships listed for these individuals have been mitigated.
Corporate Support
The project described was supported by Grant number 1 NU58DP006908-03-00 – Component A; Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services, Centers for Disease Control and Prevention.
Online Activity Refund Policy
- Requests for cancellations and refunds must be received in writing to education@rheumatology.org within 24 hours of the online activity enrollment date.
- Completed online activities are not eligible for a refund.
- Refunds will be subject to an administration fee per person and per activity: 15% for members; 30% for potential members.
- Canceled online activities are nontransferable.